^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    rocapuldencel-T (CMN-001)

    i
    Associations
    News

    Trials

    Company:
    CoImmune, SCM Lifescience
    Drug class:
    Immunostimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer (NCT02662634)
    Phase 2
    GU Research Network, LLC
    Withdrawn
    Last update posted :
    03/18/2022
    Initiation :
    03/01/2016
    Primary completion :
    03/01/2018
    Completion :
    03/01/2018
    CD8
    |
    cisplatin • carboplatin • albumin-bound paclitaxel • pemetrexed • rocapuldencel-T (CMN-001)
    Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery (NCT02944357)
    Phase N/A
    Mayo Clinic
    Withdrawn
    Last update posted :
    11/17/2017
    Initiation :
    11/01/2016
    Primary completion :
    09/05/2017
    Completion :
    09/05/2017
    CD8 • PD-1
    |
    PD-1 elevation
    |
    cisplatin • gemcitabine • rocapuldencel-T (CMN-001)